Georgia Southern University

Digital Commons@Georgia Southern
Electronic Theses and Dissertations

Graduate Studies, Jack N. Averitt College of

Fall 2013

Effectiveness of a Training Program Using an Alter-G
Treadmill to Improve Physiological and Psychosocial
Measures in Female Breast Cancer Survivors
Ciaran Fairman

Follow this and additional works at: https://digitalcommons.georgiasouthern.edu/etd
Part of the Exercise Science Commons

Recommended Citation
Fairman, Ciaran, "Effectiveness of a Training Program Using an Alter-G Treadmill to
Improve Physiological and Psychosocial Measures in Female Breast Cancer Survivors"
(2013). Electronic Theses and Dissertations. 877.
https://digitalcommons.georgiasouthern.edu/etd/877

This thesis (open access) is brought to you for free and open access by the Graduate Studies, Jack N.
Averitt College of at Digital Commons@Georgia Southern. It has been accepted for inclusion in
Electronic Theses and Dissertations by an authorized administrator of Digital Commons@Georgia
Southern. For more information, please contact digitalcommons@georgiasouthern.edu.

Effectiveness of a training program using an Alter-G treadmill to improve physiological
and psychosocial measures in female breast cancer survivors

by
CIARAN FAIRMAN
(under the direction of Kristina Kendall)
ABSTRACT
Breast Cancer survivors often experience lower bone mineral density following treatment, and
may be at a higher risk for osteoporosis and consequent falls and injuries. This study aimed to
build on previous research using lower impact exercise programs by using an anti-gravity (AlterG) treadmill to administer cardiovascular training. PURPOSE: The purpose of this study was to
determine the effectiveness a physical activity program, including an anti-gravity (Alter-G)
treadmill at improving physiological and psychosocial measures in female breast cancer
survivors. METHODS: Five female breast cancer survivors were recruited to participate in the
study. A 14-week intervention using an AB-AB study design was employed. Participants
attended three 60-minute sessions per week, consisting of a combination of muscular
strength/endurance, and cardiovascular endurance exercises. Consistent with current literature
and guidelines, exercise interventions were individualized and tailored to suit individuals.
RESULTS: Statistical analysis yielded no significant (P>0.0036) difference in measures of
cardiovascular endurance, body composition, and quality of life between pre/post measurements.
However, visual analysis of results found improvements in cardiovascular endurance and
measures of body composition. Quality of life was maintained throughout the study. Finally, no
adverse effects were reported from the participants. CONCLUSIONS: The results of this study
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suggest that the use of an anti-gravity treadmill in combination with a physical activity program
may be a safe, alternative means of improving cardiovascular endurance. Finally, an
individualized physical activity program in combination with an anti-gravity treadmill may
provide practical and meaningful improvements in measures of cardiovascular endurance and
body composition.
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CHAPTER I
INTRODUCTION
Cancer is a major health issue in the United States (U.S.) and breast cancer in particular is
one of the more prevalent forms of the disease. An estimated 1,638,910 new cancer cases for
2012 with 226,870 cases of breast cancer were expected to occur for the year in 2012 (American
Cancer Society, 2012).
Major risks of cancer are a combination of modifiable and non-modifiable risk factors.
Modifiable risk factors include increased body weight and Body Mass Index (BMI), unhealthy
diet (regular consumption of foods high in sugar and fat, and regular consumption of alcohol) ,
and a sedentary lifestyle; whereas non-modifiable factors include gender (females are at greater
risk than males), increasing age, family history and possibly an increased exposure to hormones
testosterone and progesterone due to early menstruation (before 12 years old) or late menopause
(after age 55) (CDC, 2012; Irwin a, 2012; ACS 2012).
The American Cancer Society also states that survival rates for breast cancer have risen
from 63% in the early 1960’s to almost 90% today, with over 2.9 million survivors in the U.S.
(American Cancer Society, 2012). This survival rate is most likely due to increased awareness,
earlier detection, along with advances in treatment. Consequently, this means that more women
are living with the negative effects of cancer (Sprod, 2009), either by the disease itself, or as a
result of treatment (radiation, chemotherapy, hormonal therapy etc.). Some of the negative
effects include cancer related fatigue (CRF), pain, irregular sleep pattern, and decreased
cardiovascular and pulmonary function (Irwin b, 2012).
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Physical activity (PA) has been concluded to be a safe and effective treatment to
attenuate the aforementioned negative effects for breast cancer survivors both during and post
treatment. (Sprod, 2009; Schmitz, Kathryn H., Kerry S. Courneya, Charles Matthews, et al,
2010; Irwin, 2012) However, despite the strong growing evidence of the health promoting effects
of PA, and the subsequent recommendations for levels of PA for survivors (150 min/wk of
moderate to vigorous physical activity following treatment) the majority of women reach
insufficient levels of PA (Irwin, 2008). Harrison et al assessed the PA levels of 287 breast cancer
survivors in 6 month intervals up to 18 months post-diagnosis. Although almost 80% of
survivors reported some sort of PA during the testing intervals, only 45% were considered to
have met national guidelines for survivors (defined as moderate-intensity activity on 5 or more
days for at least 30 min or vigorous activity on 3 or more days for at least 20 min) (Harrison,
Hayes and Newman, 2008)
Several researchers have found specific barriers to physical activity in cancer survivors.
These barriers include the non-availability of insurance coverage, reluctance of oncologists to
prescribe PA, a lack of prioritization of PA in healthcare settings, and some confusion of patients
as to whether PA increases survival (Irwin, 2008). Blaney and colleagues found additional
barriers including physical deconditioning, social isolation, lack of confidence due to self-image,
lack of exercise facilities & programs directed at patients (Blaney et al, 2012). Thus it appears
that the availability, promotion, and acceptance of exercise programs directed at survivors are all
important factors to increase their levels of physical activity.
Previous research directed at breast cancer survivors typically involved a 12-16 week
program including a combination of flexibility, resistance, balance and cardiovascular training.
15

Exercise programs have generally utilized a treadmill, elliptical or a stationary bike to provide
the cardiovascular training. Recognizing the need for more low impact exercises with survivors,
particularly with their increased risk of osteoporosis and fracture after treatment (Chen et al,
2005), researchers have examined the use of a water-based exercise programs to unweight the
participant and lower the impact even further (Fernández-Lao, Cantarero-Villanueva, ArizaGarcia, Courtney, Fernández-de-las-Peñas, and Arroyo-Morales,2013). These studies provide
important implications that lower impact exercises may be a feasible and well-tolerated
alternative to load bearing activities such as treadmill training for breast cancer rehabilitation.
This study aimed to build on studies with lower impact exercise programs by using an
antigravity (Alter-G®) treadmill to administer cardiovascular training.
The antigravity treadmill (Alter-G ®) is a relatively new piece of equipment used in a
range of settings from physical therapy to sports performance. This treadmill uses a chamber
attached to a pair of modified shorts at waist-level. The chamber calibrates to match air pressure
to the patient’s body weight. After calibration, the treadmill can then increase air pressure inside
the chamber to ‘unweight’ the participant to as low as 20% of their body weight (Alter-G, 2012).
The Alter-G treadmill builds on the premise set forth by the aquaciser treadmill by using
pressure to unweight the participant; the advantage of the Alter-G is that it allows the technician
to modify the air pressure in the chamber, providing a range from 20- 100% of the participants’
body weight. This range allows participants to start at a relatively low weight on their bones and
joints. They can gradually increase the percentage throughout the duration of the program to
eventually reach 100% body weight. While still a relatively new tool for physical therapy,
several studies have found positive results that support its safety and efficacy in training stroke
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patients, lower body injuries (Saxena & Granot, 2011; Tenforde et al, 2012), and obese patients
(Simonson et al, 2011).
The goal of an exercise program for cancer survivors is to help them regain independence
while improving physiological function. Supervised exercise programs may act to utilize social
support from health professionals to improve the survivors’ quality of life and avoid physical
inactivity (Schmitz, Kathryn H., Kerry S. Courneya, Charles Matthews, et al, 2010).
Purpose
The purpose of this study was to determine the effectiveness a physical activity program
including an anti-gravity (Alter-G) treadmill in improving physiological and psychosocial
measures in female breast cancer survivors.
Research Questions
The research questions for this study are:
 RQ1- Investigate if the physical activity intervention will improve quality of life among
participants.
 RQ2- Evaluate the effectiveness of the intervention at improving physiological measures
including resting heart rate and blood pressure, body composition, mobility & flexibility,
and aerobic capacity.
Hypothesis
The hypotheses for this study are


A 5 week physical activity program including resistance, balance, flexibility and
cardiovascular training will illicit improvements in quality of life
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Participants will show improvements in measures of flexibility, balance/mobility,
resting heart rate/ blood pressure and cardiovascular endurance (Compared to pre
testing/baseline or during each of the treatment phases compared to baseline and
return to baseline phases) following the program

Limitations
The following are limitations of the study:


The small sample size of the study may have been a limitation of the study;
however the design of the study allowed for participants to be their own control,
which strengthened the design.



Participants will have had different stages & duration of cancer, as well as
different modes of treatment, which could affect generalizability.



The AB-AB design may not have been sensitive enough to detect changes in
physiological variables, which can have a delay in returning to baseline.

Delimitations
The following are delimitations of the study:


Participants were recruited from a small rural area in the Southeast.



Participants were all female between the ages of 18 and 65.



Participants were at least 6 months post treatment.

Assumptions
The following are assumptions of the study:


Equipment was properly calibrated and functioned properly for testing and
training sessions.



Participants gave 100% effort during training and testing.
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Participants did not change their dietary habits.



Participants did not take part in external physical activity.



Participants provided honest and accurate answers on surveys.

Operational Definitions
Cancer: “A group of diseases that cause cells in the body to change and grow out of control”
(Breast Cancer facts & figures, 2012)
Cancer Related Fatigue (CRF): “persistent subjective sense of physical, emotional or
cognitive tiredness or exhaustion related to cancer & cancer treatment that is not proportionate to
activity & interferes with normal functioning” (Blaney et al, 2010)
Cancer Survivor: “any individual that has been diagnosed with cancer from the time of
discovery and for the balance of life” (Scmitz et al, 2005)
Cachexia: “A multifactorial syndrome characterised by an ongoing loss of skeletal muscle mass
(with or without loss of fat mass) that cannot be fully reversed by conventional nutritional
support and leads to progressive functional impairment.” (Fearon et al, 2010)
Radiation: A form of treatment typically used for localized tumors. It is used to kill cancer cells
and shrink tumors. Radiation may come from outside the body (external beam) or using
radioactive material place inside the body (internal radiation). (ACSM/ACS, 2013)
Chemotherapy: Treatment that kills cancer cells by stopping growth and division (ACSM/ACS,
2013). Chemotherapy attacks rapidly dividing cells; often times this results in damage to
otherwise healthy cells (red/ white blood cells, cells that line mouth and intestines, and hair
growth).
19

Hormonal treatment: treatment that is used to block the body’s natural hormones. Often used
to lower estrogen levels and subsequent growth of breast cancer cells (Breast Cancer facts &
figures, 2012)
Post treatment: Survivors that have completed all treatment (chemotherapy, radiation, hormonal
therapy, targeted therapy etc.) for at least 6 months.
Respiratory exchange ratio (RER): Ratio of oxygen consumption to carbon dioxide
production. Often used as a measured of substrate utilization during exercise. A value of 1.0 is
representative of 100% carbohydrates and .7 100% fat. (Powers, & Howley, 2001)
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CHAPTER II

REVIEW OF LITERATURE

An increasing number of studies have emerged promoting exercise and PA as a means to
attenuate the side effects and improve cancer related quality of life among survivors. Several
studies have hypothesized, with relative success, that exercise can be used to prevent, attenuate,
treat and rehabilitate the physiological and psychosocial challenges faced by survivors (Schmitz,
Courneya, Matthews, et al, 2010; Schneider, Hseih, Sprod, Carter, & Hayward, 2007; Sprod et
al, 2009).
Quality of life
Chen et al (2010) studied the effects of regular exercise on quality of life (QOL) (General
Quality of Life Inventory-74) in cancer survivors from baseline to 36 months post treatment.
Participants (n=1829) were interviewed about their PA levels at each stage of assessment and
assigned a metabolic equivalent task (MET). QOL was measured 6 months and 36 months after
treatment. Regular exercise was found to have a significant positive effect in both measurements
(at 6 and 36 months) of QOL. Participants with ≥8.3 MET experienced higher total scores on
physical, psychosocial measurements along with an increase in social well-being.
A systemic review of 9 studies by Bicego et al (2008) analyzed the effects of different PA
interventions as a means to improve quality of life (QOL) among participants. The duration of
studies reviewed was between 8 and 24 weeks. Interventions ranged from gentle seated
exercises, Tai Chi to more intense aerobic and resistance training. The researchers noted a
21

significant increase in Quality of life among intervention groups in comparison to control groups
(although further reviews to determine the effect of different lengths of an intervention on QOL
in survivors is warranted).
Schneider, et al (2007) investigated prescriptive exercise to improve muscular fitness,
depression and quality of life in cancer patients. 135 women diagnosed with breast cancer were
recruited for the study. Participants joined in a 6 month exercise program; with two to three
sessions per week of a combination of aerobic and resistance training.
Their results demonstrated significant improvements in muscular fitness (p=.006),
depression and quality of life (p=.0012) among survivors. Their findings suggested that utilizing
moderate individualized, prescriptive exercise is a safe and efficacious means to improve quality
of life and physical function in cancer survivors.
Cancer related Fatigue (CRF)
Peutz and Herring noted that approximately 50%-90% of cancer patients experience
fatigue during treatment. For the majority of patients this fatigue remains apparent even after
treatment has concluded. The researchers carried out a meta-analysis of 70 studies during and
post-treatment. They found that over 90% of the studies reviewed during treatment, and 85% of
the studies that reviewed post treatment interventions significantly decreased CRF (Puetz,
Herring, 2012). They also noted that larger reductions of CRF in the post treatment group and
greater improvements witnessed in studies with a longer time between treatment and program
initiation.
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A study done by Hsieh et al (2008) investigated the effects of an exercise intervention on
physiological functioning and levels of fatigue in breast cancer survivors undergoing numerous
clinical treatments. Patients performed a combination of stretching and aerobic and resistance
training, two to three days a week for six months. Researchers found a significant decrease in
fatigue and a concurrent improvement in cardiopulmonary function regardless of type of
treatment received.
Velthuis, Agasi-Idenburg, Aufdemkampe and Wittink (2010) conducted a review of 19
studies to determine the effects of PA on CRF. Studies were grouped into either home-based or
supervised exercise programs. Of the 18 studies reviewed, 12 were with breast cancer survivors,
with 6 being of other cancer types. Their analysis found home-based exercise programs showed
no significant reductions in CRF, whereas the supervised exercise programs were more effective
in significantly reducing CRF. Reviews concerning breast cancer survivors in particular found
significant improvements during supervised aerobic programs.
Schneider et al (2007) divided 113 Breast cancer survivors into groups depending on
whether they were receiving an exercise intervention during treatment, or post treatment. After a
6-month treatment period, the effectiveness of the intervention was analyzed. Both during and
post treatment groups showed significant reductions in behavioral, sensory and total fatigue (on
the Piper Fatigue Inventory).
Physiological functioning
PA has been shown to induce physiological benefits; however some survivors may be
limited in their activity by cancer related fatigue (Stasi, R., Abriani, L., Beccaglia, P., Terzoli, E.
& Amadori, S., 2003).
23

Twiss, Waltman, Berg, Ott, et. al(2009) conducted a 24 month long study to examine the
effects of an intervention of strength and weight exercises on breast cancer survivors who had
experienced bone loss. The study included both an exercising group (n=110) and a control group
(n=113). The program comprised of home and fitness center based exercises, with measurements
of strength (using Biodex ®) and balance (Timed Backward Tandem Walk) taken at baseline and
every 6 months thereafter. After analysis of measurements, researchers found “meaningful gains
in muscle strength and balance”(Twiss, Waltman, Berg, Ott, et. al, 2009, p 25).
The study also reported an adherence rate of almost 70% over 2 years. The researchers
noted several reasons for participant dropout (lack of time, chronic pain, osteoarthritis and
injury/fractures) that can help researchers navigate these in the future and aim to increase
adherence rates.
In a previously mentioned study, Schneider et al (2007) also found significant
improvements in physiological measurements in breast cancer survivors both during and post
treatment following a 6 month supervised exercise intervention. The during treatment group also
showed an increase in cardiopulmonary function (as measured by systolic blood pressure and
time on treadmill) with the post treatment group showed reductions in blood pressure and resting
heart rate.
A study done in 2009 by Sprod et al compared the physiological and psychological
effects of three versus six months of exercise training in breast cancer survivors. Survivors either
completed a 3-month (n=29), a 6-month (n=68) or no treatment (n=17) exercise intervention
during the experiment. Pulmonary function was assessed via forced vital capacity (FVC) and
forced expiratory volume in one-second (FEV1). Muscular endurance was measured using a
24

battery of tests developed specifically for cancer survivors (weight lifted was determined by
body weight and age of survivor, and repetitions were performed at a rate of 12.5 repetitions per
minute until volitional fatigue). The results showed that 3 months of exercise improved
symptoms of depression, fatigue and cardiovascular endurance. Further improvements in
muscular endurance and pulmonary function were shown in the survivors who exercised for 6
months. This study highlights the efficacy of interventions of longer length to illicit further
improvements in physiological variables and attests to importance of survivors to maintain an
exercise program.
More recently, Saarto & colleagues (2012) examined the effects of a 12 month combined
step aerobic and circuit-training program on bone mineral density (BMD) at the lumbar spine
and femoral neck in pre and post-menopausal breast cancer survivors (n=498). The intervention
consisted of one supervised session and two to three home based sessions a week. The
supervised session alternated between a vigorous step aerobics session and a circuit training
session weekly. Similar exercises were prescribed for home-based sessions to ensure a minimum
of three sessions per week. Bone loss managed to be prevented in the intervention group for
premenopausal women; with lumbar bone loss being unable to be prevented. Researchers found
no significant effect of exercise on BMD at either femoral neck or lumbar spine. Bone loss in
post-menopausal survivors was attributed to age, menopause, and even older participants lower
physical performance and resulting lower level of training intensity to induce bone loading.
Nonetheless, this study shows promise to the efficacy of supervised exercise programs at
preventing bone loss in premenopausal survivors.
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Anti-gravity training
Figueroa, Manning & Escamilla (2011) investigated the difference in metabolic work
when using an anti-gravity treadmill, at different percentages of body weight (80%, 90%, &
100%) compared to jogging to maximal aerobic capacity. Testing of 10 subjects occurred on
three separate days at three different percentages of their body weight. Each testing session was
separated by two weeks. Maximal oxygen consumption (VO2 max) was measured using a
modified Bruce Protocol. Additionally, caloric expenditure (kcals), substrate utilization (RER),
rating of perceived exertion (RPE) and HR response of participants while jogging were all
measured. Relative and absolute VO2max values were not significantly different at any body
weight percentage compared to running regularly. Similarly, HR and RER were not significantly
affected by the reduction in body weight. This study provides promising evidence in support of
the use of unloading a participant to reduce ground reaction forces and subsequent impact on
their bones and joints, yet maintaining the same metabolic responses to exercise. Future research
may need to investigate the effects of reducing the percentage of body weight even further (70%,
60% & 50%). This line of research examining low impact exercises on physiological variables in
breast cancer survivors is promising, yet further research is warranted to determine the most
effective types of interventions.
The American College of Sports Medicine (ACSM) recently conducted a roundtable to
review the current literature and ultimately conclude that exercise training is safe during and
post- treatment and can result in improvements in cancer related fatigue, Quality of life, and
physical functioning. (Schmitz, Courneya, Matthews, et al, 2010) The focus was on adult cancers
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where most evidence had been assembled (breast, prostate, colon, adult hematologic, Adult
HSCT & gynecologic).
These guidelines were developed based on existing ACSM, AHA, ACS and 2008 US
department of Health and Human Services recommendations. The roundtable highlighted that the
study of the safety and efficacy of exercise is an emerging one; consequently, literature should be
reviewed frequently.
Detailed guidelines for prescription of exercise including pre assessment, contraindications,
and progression for different types of cancer are provided in the roundtable (Schmitz, Courneya,
Matthews, et al, 2010) but some of the key findings are outlined below.
●

Exercise prescription should be individualized to each survivor based on their
pretreatment physical assessment, medical history, response to treatment and apparent
contraindications.

●

Maintaining and increasing muscle mass is recommended for all survivors.

●

85 studies reviewed, with consistent evidence found on the safety and efficacy of exercise
before and after treatment.
○

Some exercise induced improvements consistently found in reviewed studies:
Quality of Life, fatigue, aerobic fitness, muscular strength, and endurance

The roundtable also emphasized two limitations of current research;
●

This field of research is in its adolescent stages, thus studies have focused on the efficacy
and feasibility of exercise as opposed to the effectiveness and generalizability
27

●

There is a need for greater specificity and consistency between studies on optimal doseresponse and the effects of particular types of training before and after treatment.
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CHAPTER III

METHODS
Participants
Participants of the study (n=6) were female breast cancer survivors (51±18 years old).
One participant dropped out of the program due to an extended vacation taken towards the end of
the study. Participants were recruited through a number of measures, primarily word of mouth
and recruitment flyers. Each participant was given a numerical code to identify them objectively
and protect their identity. Prior to participation, all participants were required to complete a
cancer specific PAR-Q a written statement of informed consent, and a form providing
physicians’ release to participate in the study. This study was approved by the University’s
Institutional review board (H13160).
Inclusion/Exclusion Criteria
The inclusion/exclusion criteria for participation in the study are outlined below:
Table 1: Inclusion/Exclusion Criteria
Inclusion Criteria
Female
Breast Cancer Survivor

Exclusion Criteria
Outside 18-65 years old
Currently receiving treatment (Chemotherapy,
Radiation, hormonal etc.)
Contraindicated to exercise (Appendix G)
Without a physician referral
Cancer other than breast

At least 6 months post treatment
18-65 years old
Participant is willing and able to complete the
protocol
Participant has received physician’s clearance
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Equipment
●

The Alter-G treadmill

This was a primary component of the aerobic training portion of the program. Participants began
at a percentage of their body weight that they felt was comfortable (at least 50%). Progression to
higher percentages was individualized, gradual and measured on a combination of the
participant’s ability, and the exercise specialist’s assessment of their ability to progress.
●

Other equipment used in the program included; free weights, BosuTM balls, resistance
bands, weight training machines.

Measurements
(Further detail & instructions provided to participant are outlined in the appendices)
●

Resting Heart Rate (beats per minute, BPM) & Blood pressure (mmHg)

●

Cardiovascular endurance via treadmill time

●

Functional Balance- Timed “Get Up and Go” (in seconds)
○

Get Up and Go Test begins with the participant sitting in a chair. Their score is
based on the time it takes them to rise from the chair, walk three meters, turn and
return to the chair.

●

Flexibility- modified sit and reach (cm)

●

Body composition - circumference (cm), weight (kg)
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Procedure
The Alter-G treadmill intervention closely followed interventions by Schneider et al,
(2007) and guidelines recently released by the ACSM (Schmitz et al. 2010,) for safe and
efficacious training with cancer survivors. The program included a screening week, where
participants filled out informed consent forms and were given an overview of what the study
would consist of. Participants were asked to sign a University research participation release form
prior to beginning the program.
This study focused on recommendations for pre-exercise assessments, exercise
prescription and programming adaptations from ACSM’s newly released Guide to Exercise and
Cancer Survivorship (2012). The primary investigator was a certified professional with an
extensive background working with cancer survivors. The investigator was able to modify, adapt
and individualize exercise prescription as needed.
Exercise prescription was based on initial assessments of cardiorespiratory fitness,
muscular strength and endurance, flexibility, range of motion and body composition (Sprod,
2009). Screening and training protocol closely followed the American College of Sports
Medicine (ACSM) contraindications and precautions for exercise and testing patients with
cancer (Schmitz et al. 2010).
Rate of perceived exertion (RPE) was monitored throughout each session (Sprod, 2009)
using Borg’s modified RPE scale (Borg, 1982). The modified Borgs scale is a commonly utilized
tool to evaluate perceived exertion of exercise sessions. This scale is numbered 1-10 (10 being
highest level of perceived physical exertion, 1 being the lowest); participants are asked how they
felt the intensity of an exercise or session was on the scale of 1-10. The reliability of this scale
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has been found to be high (r = 0.80–0.90) (Chen, Xitao and Moe, 2002) and it’s validity to be
high (r= ~64) (Karavatas and Tavakol, 2005).
Research Design
A single case AB-AB designed was employed (Kazdin, 1982). The design consisted of
four phases: (A) a baseline testing phase to establish initial conditions and performance, followed
by (B) an intervention phase (4 weeks) followed by (A) a return to baseline (2-3 weeks) and (B)
a final replication phase. This design is unique in that it employs multiple baselines, allowing for
each participant to serve as their own control. Continuous testing was performed three times a
week throughout the program. The result of each assessment for each variable was plotted along
a graph. Using ocular statistics, these scores were observed and evaluated to determine if the
treatment was effective.
Below is an outline of sessions and visits with the program:
Week 1 – Visit 1
-Consisted of initial screening and testing. Participant’s physician clearance form was
reviewed, along with PAR-Q. Participants were given an orientation into the study, a
demonstration of some of the equipment, particularly the Alter-G treadmill, and an overview of
the timeline of the study.
Week 1 – Visit 2: Baseline Testing (BT)
-Regular testing (RT) was performed prior to each session. Participants resting heart rate
and blood pressure were taken along with assessments of flexibility & balance/mobility.
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Baseline testing was performed once a week and consisted of the regular testing outlined
above, with additional measurements of body composition, Quality of Life and cardiovascular
endurance.
Balance/Mobility
-Functional balance was measured with a timed “Get-up-and-Go” (GUG) test. The GUG
test consisted of time measurements of the participants starting from a seated position, standing
without the help from their hands, walking forward three meters, turning around, walking back to
the chair, and sitting down without use of their hands. Time was measured in seconds.
Flexibility
-A modified sit and reach test was used to measure flexibility. Participants sat in a chair
with one leg outstretched. They then slid their hands as far down their outstretched leg as
possible. Flexibility was measured by the distance between the participant’s fingertips and their
toes.
Body composition
-Body composition was tracked using a combination of circumference, waist-to-hip ratio,
and weight.
Quality of Life
-Measured using Ferrans and Powers QUALITY OF LIFE INDEX© CANCER
VERSION – III. This is a survey used to establish a client’s satisfaction in various areas of their
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life. (Appendix) The survey is a 6-point Likert-type scale determining participants’ satisfaction
& perceived importance of different aspects of their life.
Cardiovascular endurance
Cardiovascular endurance was measured through the use of a modified Balke protocol
(Appendix F). This test was administered on a traditional treadmill as no protocols have been
established for use on the Alter-G treadmill. Participants were asked to walk until volitional
fatigue. Total time on the treadmill was recorded.
Week 1 - Visit 3
Training sessions began on the third visit. Sessions consisted of a combination of
flexibility, balance and resistance exercises.
Week 2 – Visit 4-6
-These visits included the same procedure as the third visit; sessions comprised of
flexibility, balance and resistance training.
Weeks 3-7 – Visits 7-21
-These visits included the training sessions as interventions. RT was performed at the
beginning of each session, followed by a combination of resistance, aerobic and flexibility
training. The Alter-G treadmill was introduced in the program. Participants all began at a
percentage of their bodyweight they felt they could comfortably walk at (at least 50%).
Weeks 8-9 - Visit 22-28
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-This “return to baseline” phase included the removal of the Alter-G treadmill. There was
no structured cardiovascular training performed during this time. However, resistance, flexibility
and balance training were all maintained during this period.
Weeks 10-14 - Visit 29-45
-Return to treatment. The Alter-G treadmill was reintroduced. Procedure for this phase
was the same as visits 7-21.
Below is a visual outline of the timing of the phases during the study.

Behavior/physiological condition

Figure 1: Timing of Phases in AB-AB Design

Baseline
(A Phase)

Intervention
(B Phase)

Return to
Baseline
(A)

Final
replication
(B)

Weeks 1-2

Weeks 3-7

Weeks 8-10

Weeks 11-15

Weeks 1-2

Weeks 3-7

Weeks 8-9

Weeks 10-14

Phase
Exercise prescription
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The program consisted of muscular strength and endurance, and cardiovascular
endurance exercises. Consistent with current literature and guidelines, exercise interventions
were individualized and tailored to suit individuals.
General standards of exercise intervention included:
●

60-minute sessions 2 days per week (a minimum of 24 hours rest was required between
training days). A third day each week was used for testing.

●

Warm-up, followed by bouts of aerobic, resistance, balance and flexibility training,
followed with a cool down.

●

RPE was used to monitor & adjust levels of intensity for both aerobic and resistance
training

●

Participants began with 1-2 sets of 12-15 repetitions; gradually increasing to 3 sets of 810 repetitions.

Table 2: Sample Session
Tests

Set 1

Set 2

Set 3

(weight/reps)

(weight/reps)

(weight/reps)

Heart Rate/Blood
Pressure
GUG
Flexibility
Exercises
Push ups
Pull ups
Body weight squats
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Leg Press
Leg Extension
Leg Curls
Curls
Tricep Extension
Foam pad timed leg
stand
Bosu ball balance throw
PNF stretching

Alter-G Protocol
Participants began the aerobic training at a percentage of their body weight they felt
comfortable (at least 50% of their body weight). The percentage of body weight was increased as
participants’ improved and progressed throughout the program. Aerobic exercise was performed
for a minimum of 30 minutes each session. Intensity was manipulated by increasing the
percentage of weight the participants worked at, and/or the speed of the treadmill.
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CHAPTER IV
RESULTS
Data Analysis
Visual inspection was used to analyze changes in magnitude (mean and level) and the
rate of change (trend and latency)(Kazdin, 1982).
Mean: The mean of each phase was calculated. Using the mean from baseline, we can predict
the future performance of the participant if no change were to occur and from this compare the
mean determined from the intervention to infer the magnitude of change.
Level: The level of each refers to the difference between the last measurement of one phase to
the first measurement of the following phase. Essentially, this allows one to infer how great of a
change occurred when a phase shift occurred.
Trend: The trend refers to the direction of the data throughout the intervention. Through visual
inspection, one can look at the trend of measurements either increasing or decreasing concurrent
with each appropriate phase, which may add strength to the hypothesis that the change is a result
of the presence or lack of an intervention.
Latency: Latency refers to how quickly after a change of phase does a change in measurement
occur. An immediate increase of decrease in measurements, for example, would suggest that it
was a phase change that caused the different measurements than a change that happened later.
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Characteristic

(mean ±SD)
51±18
166.12±17.78
73.12±45.8

Age(yrs)
Height (cm)
Weight (kg)
Cancer stage
0
1
2
3
4

0
1
4
0
0

Radiation
Chemotherapy
Hormonal Therapy
Surgery

2
5
2
5

Treatment

Table 3 – Subject Characteristics (n=5).
Participant 1 (P1)

Balke Protocol

18
16
14

Time (minutes)

12
10
8

6
4
2
0
1

3

5

7

9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45
Session number

Figure 2 – Balke Protocol (P1)
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The mean treadmill time for the first baseline phase was 9.25 minutes; 12.04 minutes for
the return to baseline phase and 13.99 for the second intervention phase 12.03 minutes followed
the mean for the final replication phase. There was an increase in mean between the first baseline
and first intervention phases, followed by a stable mean between the first intervention and the
return to baseline phase, with a subsequent increase in mean in the replication phase from the
return to baseline phase. There was little change in level between phases although there was
evidence of an increasing trend in treadmill time in both intervention phases. The latency of
change was not immediate although evident in both intervention phases with respect to the
preceding baseline phases.
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Sit and Reach
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8
6
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2
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Figure 3 – Sit and Reach (P1)

The average score for baseline one was 4.17cm, with the first intervention having a mean
of -5.34cm, return to baseline mean of -7.08cm and a final replication mean of -6.28cm. There
was a slight change in level between the first baseline phase and the first intervention phase, and
another slight change in level seen between the return to baseline phase and final replication
phase. There was an apparent trend in increase of flexibility from the first baseline to the first
intervention phase, followed by a leveling of scores from the return to baseline to final
replication. The latency of change was evident in the first baseline to the first intervention
(although there was already a downward trend in scores during the first baseline phase) and a
subsequent change in latency evident in the return to baseline to final replication phase.
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Get Up and Go
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Time (seconds)

8
6
4
2
0
0

2

4

6

8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44 46 48
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Figure 4 – Get up and Go (P1)

The first baseline phase exhibited a mean of 9.2 seconds (s), with the first intervention
phase displaying a mean of 6.14s, followed by a mean of 5.89s in the return to baseline phase
and a mean of 5.33s in the final replication stage. There was little to no apparent change in level
between each of the four phases. There was evidence of a trend with a slight improvement of
scores across baseline and the first intervention phase followed by an apparent plateau in scores.
There was slight evidence of a change in latency at the onset of the first intervention phase from
baseline and then again in the final replication phase from the return to baseline phase.
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Weight
120

Weight (kg)
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118.5
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117.5
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Session number

Figure 5 – Weight (P1)

The mean weight for the first baseline phase was 119.6kg; the mean for the first
intervention phase was 118.6kg.The means for the return to baseline and final replication were
119kg and 119kg, respectively. There was little change in level across the four phases of the
study. There was a relatively stable trend in both baseline phases with a trend of a decrease in
weight in both intervention stages. Finally, the latency of change was apparent, although not
immediate in both intervention stages.
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Waist to Hip ratio
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Figure 6 – Waist to Hip Ratio (P1)
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The mean waist to hip ratio (W/H) was .91 for the first baseline phase, .87 for the first
intervention phase and the return to baseline phase, and.84 for the replication phase. There were
slight changes in level evident between the first baseline phase and the first intervention phase,
the first intervention and return to baseline phase, and finally the return to baseline phase and
final replication phase. There was a stable trend in the first baseline phase, followed by a
decreasing trend in the first intervention phase. There was a stable trend in the return to baseline
phase with no apparent trend in the final baseline phase. The latency of change was evident,
although slightly delayed in both intervention phases with respect to the preceding baseline
phases.

Blood Pressue(mmHg) and Heart Rate (BPM)

160

Resting Heart Rate & Blood Pressure

140
120
100
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80
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DBP
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20
0
0

2

4

6

8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44 46 48
Session Number

Figure 7 – Resting Heart Rate & Blood Pressure
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The mean RHR for Baseline 1 was 69.5 bpm, followed by a mean of 70.3bpm for the first
intervention phase, 70.3 bpm for the return to baseline phase, and 67.4 bpm for replication phase.
There was relatively little change in level between each phase. There was no obvious change in
trend throughout the study. The latency of change was not obvious between phases.
The mean systolic blood pressure (SBP) for the first baseline phase was 127.67mmHg,
with a mean of 125.13mmHg for the first intervention phase. The mean blood pressure for the
return to baseline phase was 127.5mmHg with a mean of 125.8mmHg for the final replication
phase. There was little evidence of change in level between phases with the exception of the
baseline 2 and final replication phase. There was evidence of a slight increasing trend in SBP in
baseline, followed by a slight decrease in the intervention phase, a relatively stable return to
baseline phase, and a curvilinear decrease in the final replication phase.
The mean diastolic blood pressure was 77.6mmHg for the first Baseline phase, followed
by a mean of 81.78mmHg for the first intervention phase, 77.4mmHg for the return to baseline
phase and 76.06mmHg for the final replication phase. There is little change in level between
each phase. There is no apparent trend throughout the phases. The latency of change is not
evident between phases.
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Quality of life
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Figure 8 – Quality of Life (P1)

The mean total quality of life for the first baseline phase was 20.70, 24.86 for the first
intervention phase, 25.06 for the return to baseline phase. The mean for the final replication
phase was 26.23. There was a slight change in level between the first baseline phase and the first
intervention phase, with little change across the subsequent phases. There was no apparent
change in trend across phases. There was no latency of change evident between any phase with
the exception of an immediate change apparent between the first baseline phase and the first
intervention phase.
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Participant 2 (P2)

Balke Protocol
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Time (minutes)
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Figure 9 – Balke Protocol (P2)

There was a change in mean time for the Balke protocol across all phases. The mean time
was 6.3min in baseline one, 12.8 minutes in intervention one, 14.04min in baseline two and
19.51min in intervention two. There was a slight change in level between baseline one and
intervention one. The latency of change is evident in both intervention stages. There was a trend
of increasing times in baseline one, intervention one and intervention two with a stable trend in
baseline two. The latency of change was evident, although slightly delayed in both intervention
phases.
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Figure 10 – Sit and Reach (P2)

There was a change in mean of sit and reach scores across all phases. The mean for
baseline one was -6cm, the mean for intervention one was -9.7 cm, with the mean for baseline
two and intervention two being -13.75cm and -14.94cm, respectively. A change in level was
evident from baseline two to intervention two. There was a trend of decreasing scores (increasing
flexibility) across all phases. The latency of change was not evident between any of the phases.
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Get Up and Go
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Figure 11 - Get Up and Go (P2)

The mean scores for the GUG test were 5.1s for baseline one, 4.31s for intervention one, 4.29s
for baseline two, and 4.27s for baseline two. There was a slight change in level between baseline
one and intervention one with a decrease in time, with no change in level in any other phase.
While there was a trend of decreasing time in baseline one, there was no change in trend across
the other phases. There was no latency of change between each phase.
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Figure 12 – Weight (P2)

The mean weight for baseline one was 85.6kg, for intervention one was 82.8kg, for
baseline two was 80.9kg, and a mean of 81.6kg for intervention two. There was a slight change
in level between baseline two and intervention two. There was a trend of decreasing weight in
intervention one and a curvilinear increase in intervention two. The latency of change is evident
in both intervention phases. In both phases, the change seemed occur almost immediately with
the introduction of the intervention.
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Figure 13 – Waist to Hip ratio (P2)

The mean for the first baseline phase was .84; the mean for the first intervention phase
was.80. The means for the return to baseline and final replication were both .78. Thus, there was
a .04 reduction in the mean waist-hip ratio between the first baseline and first intervention phase,
and a subsequent reduction of .02 between the first intervention and the return to baseline phase.
There was no evidence of a change in level between any of the phases. There was a trend of a
slight decrease in W/H in baseline one. There was also evidence of a slight decrease in scores in
intervention one, with an apparent increase in scores in intervention two. The latency of trend
was not immediately apparent in any of the phases.
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Figure 14 – Resting Heart Rate & Blood Pressure (P2)

The mean resting heart rate for the first baseline phase was 73 bpm, the mean for the first
intervention phase was 73bpm, with means of 69bpm and 74bpm for the return to baseline phase
and final replication phase, respectively. There was relatively little change in level between each
phase. There was also no obvious change in trend, nor evidence of latency of change between the
phases.
The mean systolic blood pressure for the first baseline phase was 121mmHg, with a mean
of 121mmHg for the first intervention phase. The mean SBP for the return to baseline phase was
124mmHg with a mean of 119mmHg for the final replication phase. There was little evident of
change in level between phases with the exception of a slight increase between the first
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intervention phase and the return to baseline phase. There was little evidence of change of trend
between phases. There was also little evidence of latency of change between phases.
The mean diastolic blood pressure for the first baseline phase was 78mmHg, with a mean
of 78mmhg for the first intervention phase. The return to baseline phase and final replication
phase had means of 78mmHg and 77mmHg respectively. Similarly, there was little change in
level between phases. There was no obvious change in trend between phases. The latency of
change was not obvious between phases.
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Figure 15 – Quality of Life (P2)

The mean quality of life for the first baseline phase was 24, with a score of 27 for the first
intervention phase. There was a mean of 27.7 for the return to baseline phase and 27.65 for the
final replication phase. There was a trend a slight increase in scores across the baseline phase and
the first intervention phase. There was no change in level apparent across phases. There was also
little evidence of latency of change across each phase.
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Figure 16 – Balke Protocol (P3)

There was a change in mean time for the Balke protocol across all phases. The mean time
was 7.8 min in baseline one, 14.19min in intervention one, 20.9min in baseline two and 28.4min
in the final replication phase. There was a slight change in level between baseline one and
intervention one. There was a trend of increasing times in both intervention phases with stable
trend in both baseline phases. The latency of change was evident, although slightly delayed in
both intervention phases.
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Figure 17 – Sit and Reach (P3)

There was a change in mean of sit and reach scores across all phases. The mean for
baseline one was -25cm, the mean for intervention one was -26cm, with the mean for baseline
two and intervention two being –28cm and -29cm, respectively. There was no obvious trend in
the first baseline phase, with a trend of decreasing scores (increased flexibility) in the first
intervention phase. The return to baseline phase and final replication phase showed a stable
trend. There was no obvious change in level across any phase. There was a slight delay in the
latency of change between the first baseline phase and the first intervention phase, with no
evidence of latency of change in the remaining phases.
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Figure 18 – Get Up and Go (P3)

The mean scores for the GUG test were 6.02sec for baseline one, 4.75 seconds for
intervention one, 4.6sec for baseline two, and 4.2 sec for the final replication phase. There was a
downward trend in the first baseline phase, with a slight downward trend in the final replication
phase. There was no apparent change in level between phases. The latency of change was not
evident between phases.
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Figure 19 – Weight (P3)

There was a change in mean between phases. The mean weight for the first baseline
phase was 46.2kg the mean for the first intervention phase was 47.86kg. The mean weight for the
return to baseline phase and final replication phase were 48.6kg and 47.5kg, respectively. There
was a change in level between the first baseline phase and first intervention phase and again
between the return to baseline phase and final replication phase. There was a trend of increase in
weight in the first intervention phase and a subsequent trend of a curvilinear decrease in weight
in the final replication phase. The latency of change was evident in both the first intervention
phase and final replication phase as changes in weight occurred almost immediately.
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Figure 20 – Waist to Hip Ration (P3)

The mean W/H was .73 for the first baseline phase, with a mean of .74 for the first
intervention phase. The means for the return to baseline phase and final replication phase were
.73 and .73 respectively. There was no change in level or trend between each phase. The latency
of change was not obvious in this phase.
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Figure 21 – Resting Heart Rate & Blood Pressure (P3)

The mean resting heart rate for the first baseline phase was 101 bpm, the mean for the
first intervention phase was 105bpm, with means of 107bpm and 104bpm for the return to
baseline phase and final replication phase, respectively. There was no obvious change in level
between phases. There was no evidence of a change in trend between phases. There was also no
latency of change in any phase.
The mean systolic blood pressure for the first baseline phase was 124mmHg, with a mean
of 125mmHg for the first intervention phase. The mean SBP for the return to baseline phase was
127mmHg with a mean of 122mmHg for the final replication phase. There was no evidence of a
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change in level or trend between phases. A latency of change between phases was also not
apparent.
The mean diastolic blood pressure for the first baseline phase was 79.5Hg, with a mean
of 76mmhg for the first intervention phase. The return to baseline phase and final replication
phase had means of 74mmHg and 73mmHg, respectively. There was no obvious change in level
or trend between phases. There was also no obvious latency of change between phases.

62

Quality of Life

30.00

Quality of lIfe score

25.00

20.00

15.00

10.00

5.00

0.00
1

2

3

4

5

6
7
8
9 10
Measurement number

11

12

13

14

15

Figure 22 - Quality of Life (P3)

The mean for the first baseline phase was 15.33, followed by a mean of 17.5 for the first
intervention phase. The mean quality of life for the return to baseline phase was 20.1 with a
score of 24.88 for the final replication phase. There was a trend of an increase in quality of life
score across all phases, with the exception of the first intervention phase, which appeared to have
an unstable trend. There were changes in level between the first baseline phase and the first
intervention phase, the first intervention phase and the return to baseline phase and a slight
change between the return to baseline phase and the final replication phase. The latency of
change was evident between the first baseline phase and the first intervention phase and between
the first intervention phase and return to baseline phase.
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Figure 23 – Balke Protocol (P4)
The mean time for the first baseline phase was 18.83min, with a mean of 34.93min for
the first intervention phase. The mean times for the return to baseline and final replication phase
were 50min and 54.2min, respectively. There was an increasing trend in the first baseline phase,
first intervention phase, and final replication phase. There was no obvious change in level
between phases. The latency of change was apparent and immediate in both intervention phases.
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Figure 24 – Sit and Reach (P4)

The mean sit and reach scores for the first baseline and first intervention phase were 1.3cm and- 14.5cm, respectively. The mean for the return to baseline phase was -14.3cm with a
mean of -16.3cm for the final replication phase. There was a decreasing trend (increased
flexibility) in the first baseline phase, and again in the first intervention phase. There was a stable
trend apparent in the two final phases. There was a change in level between the first baseline
phase and the first intervention phase and again between the return to baseline phase and the
final replication phase. The latency of change was not apparent between phases.
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Figure 25 – Get Up and Go (P4)

The mean scores for the GUG test were 4.5s for the first intervention phase, 3.8s for the
first baseline phase, 3.6s for the return to baseline phase, and 3.6s for the final replication phase.
There was a slight trend of increasing scores in the first baseline phase, with no apparent trend in
the other three phases. There was a change in level between the first baseline phase and the first
intervention phase. The latency of change was also evident between the first baseline phase and
the first intervention phase.
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Figure 26 – Weight (P4)

The mean weight for the first baseline phase was 80kg with a mean of 78.1kg in the first
intervention phase. The mean weight for the return to baseline phase and final replication phase
was 78.1kg and 76.8kg, respectively. There was a stable trend apparent in both baseline phases,
with a trend of decreasing weight in both intervention phases. The was a slight change in level
between the first baseline phase and first intervention phase, and between the return to baseline
phase and final replication phase. The latency of change is apparent, and immediate in both
intervention phases.
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Figure 27 – Waist to Hip ratio (P4)

The mean W/H for the first baseline phase was .83, with a mean of .80 for the first
intervention phase. The mean for the return to baseline phase was .78 with a mean of .80 for the
final replication phase. There was a decreasing trend of waist-hip ratio in the first baseline phase,
with no apparent trend in the first intervention phase. There was no trend in the return to baseline
phase, with a slight increasing trend in the final replication phase. There was a change in level
between the first baseline phase and the first intervention phase, the first intervention phase and
return to baseline and finally the return to baseline phase and final replication phase. There was a
latency of change in between the first baseline phase and first intervention phase, and the first
baseline phase and return to baseline phase. The latency of change was also evident in between
the return to baseline phase and final replication phase.
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Figure 28 – Resting Heart Rate & Blood Pressure (P4)

The mean resting heart rate for the first baseline phase was 68 bpm, the mean for the first
intervention phase was 70bpm, with means of 75bpm and 71bpm for the return to baseline phase
and final replication phase, respectively. There was a slight change in level between the first
intervention phase and the return to baseline phase. There was no obvious change in trend
between phases. The latency of change was also not evident between phases.
The mean systolic blood pressure for the first baseline phase was 118mmHg, with a mean
of 117mmHg for the first intervention phase. The mean SBP for the return to baseline phase was
123mmHg with a mean of 118mmHg for the final replication phase. There was no evidence of a
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change in level or trend between phases. A latency of change between phases was also not
apparent.
The mean diastolic blood pressure for the first baseline phase was 81mmHg, with a mean
of 76mmhg for the first intervention phase. The return to baseline phase and final replication
phase had means of 78mmHg and 76mmHg respectively. There was no obvious change in level
or trend between phases. There was also no obvious latency of change between phases.
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Figure 29 – Quality of Life (P4)

The mean scores for quality of life were 24.81 in the first baseline phase, 29.13 in the
first intervention phase, 29.65 in the return to baseline phase and 27.87 for the final replication
phase. The was a trend of increasing scores in the first baseline phase, with stable trend across
the first intervention phase and return to baseline phase, with a relatively stable trend in the final
replication phase. There was a slight change in level between the first baseline phase and the first
intervention phase. There latency of change was apparent between the first baseline phase and
the first intervention phase.
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Figure 30 - Balke Protocol (P5)

The mean times for the Balke protocol were 12.16min for the first intervention phase,
21.88min for the first baseline phase, 31min for the return to baseline phase and 34.2min for the
final replication phase. There was a trend of increasing time in the first intervention phase and
final replication phase. There was a change in level between the first baseline phase and the first
intervention phase. The latency of change was immediately evident between the first baseline
phase and first intervention phase.
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Figure 31 – Sit and Reach (P5)

The mean sit and reach score for the first baseline phase was -11.5cm, with a mean of 18.1cm for the first intervention phase. The means for the return to baseline phase and final
replication phases were -18.2cm, and -17.9cm respectively. There was a change in level between
the first baseline phase and the first intervention phase, and again between the return to baseline
phase and final replication phase. There was a trend of a curvilinear decrease (increase in
flexibility) in the first intervention phase; all other phases had stable trends. The latency of
change was evident between the first baseline phase and the first intervention phase, and again
between the return to baseline phase and final replication phase, with immediate responses to the
intervention
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Figure 32 – Get Up and Go (P5)
The means for the GUG test were 4.9s for the first baseline phase, 3.9s for the first
intervention phase, 4.0s for the return to baseline phase, and 4.0s for the final replication phase.
There was a trend of decreasing time in the first baseline phase, and a slight decrease in the first
intervention phase. There was a slight change in level between the first intervention phase and
the return to baseline phase. The latency of change was not evident across the phases.
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Figure 33 – Weight (P5)
The mean weight for the first baseline phase was 81.1kg, with a mean weight of 80.2kg
for the first intervention phase. The mean for the return to baseline phase was 80.4kg with a
mean or 80.5kg for the final replication phase. There was a decreasing trend in the first baseline
phase, a curvilinear decreasing trend in the first intervention phase, a stable trend in the return to
baseline phase and no obvious trend in the final replication phase. There was a change in level
between the first baseline phase and the first intervention phase, and between the first
intervention phase and the return to baseline phase. The latency of change was immediately
evident between the first baseline phase and the first intervention phase.
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Figure 34 – Waist to Hip Ratio (P5)

The mean W/H for the first baseline phase was .71, with a mean of .71 for the first
intervention phase. The means for the return to baseline and final replication phase were .70 and
.69, respectively. There was evidence of a decreasing trend in both baseline phases, and the final
replication phase. There was a change in level between the first baseline phase and the first
intervention phase, and again between the first intervention phase and return to baseline phase.
The latency of change was apparent, although slightly delayed in the first intervention phase.
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Figure 34 – Resting Heart Rate & Blood Pressure (P5)

The mean for resting heart rate was 78bpm for the first baseline phase, 84bpm for the
first intervention phase, 88.5bpm for the return to baseline phase, and 83bpm for the final
replication phase. There was no obvious trend across each phase. There was no evidence of a
change in level between each phase. The latency of change was not apparent between phases.
The mean for systolic blood pressure was 127mmHg for the first baseline phase,
125mmHg for the first intervention phase, 127mmHg for the return to baseline phase, and
125mmHg for the final replication phase. There was no obvious change in level or trend across
phases. There latency of change was not apparent between phases.
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The mean for diastolic blood pressure was 79 mmHg for the first baseline phase,
82mmHg for the first intervention phase, 76mmHg for the return to baseline phase, and 76 for
the final replication phase. There was no apparent change in trend or level between phases. The
latency of change was not apparent between phases.
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Figure 36 – Quality of Life (P5)

The mean quality of life for the first baseline phase was 25.13, with a mean of 24.65 for
the first intervention phase. The mean for the return to baseline phase was 25.07 with a score of
26.63 for the final replication phase. There was a relatively stable trend across all phases, with a
curvilinear increasing trend in the final replication phase. There was a slight change in level
between the first baseline phase and first intervention phase. The latency of change was evident
between the first baseline phase and the first intervention phase.
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Statistical Analysis
A Wilcoxon signed-rank test was used to compare the mean score of each phase to
determine if they were statistically significantly different. This test is a non-parametric version of
a dependent t-test. Seven variables were compared at two different time points for a total of 14
tests. This complex analysis increases the risk of making a type one error. To reduce this error, a
Bonferroni correction was performed and the alpha level of .05 divided by the total number of
tests performed (14) to reach a new alpha level of .0036. This new alpha level ensured the risk of
making a type one error is reduced.
Table 4 – Wilcoxon signed rank test
Pre

Post

Mean
SD
Mean
SD
z-score
p
Balke
9.688
4.46
33.9
15.24
-2.023
0.031
S/R (cm)
-2.55
14.1
-17.2
8.14
-2.023
0.031
GUG (secs)
6.95
2.36
4.14
0.61
-2.023
0.031
Weight
181.24
57.24
177.14
55.04
-1.753
0.063
W/H
0.81
0.08
0.76
0.09
-1.841
0.063
QOL
20.85
4.46
29.5
3.26
-2.023
0.031
*S/R = Sit and Reach, GUG = Get up and Go, W/H = Waist to Hip ratio, QOL, = Quality of life
**Alpha level was set to .0036
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CHAPTER V
DISCUSSION

The purpose of this study was to determine if using a physical activity program, including
an anti-gravity (Alter-G) treadmill, would aid in improving physiological and psychosocial
measures in female breast cancer survivors.
It was hypothesized that using a physical activity program including an Anti-gravity
treadmill would improve physiological and psychological measures in the participants. Based on
our results, we can conclude that a fifteen-week exercise program with a combination of
resistance, flexibility, balance and cardiovascular training with an Alter-G treadmill at least
maintained, and in some cases, improved these measures outlined below.
Cardiovascular functioning as measured by treadmill times
The Wilcoxon signed rank test, using an adjusted alpha cut off of p=0.0036 (Bonferroni
correction), showed no statistically significant improvements between pre and post
measurements. However, visual interpretation of the results suggests that all participants
experienced improvements in treadmill times during both the intervention phase and the final
replication phase. A plateau in times across both baseline phases suggests signs of decreased
cardiovascular functioning as a result of detraining (Neufer 1989). Sprod et al. (2010) noted
similar findings with significant improvements in cardiovascular functioning as reported by
treadmill times in both a 3-month and 6 month exercise group. Other researchers have found
comparable results with exercise interventions of different lengths, demonstrating significant
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improvements in cardiovascular function in female breast cancer patients, both during and post
treatment (Hseih et al, 2008; Schneider et al, 2007, Sprod et al, 2010). These results partially
support the hypothesis that using the anti-gravity treadmill as part of an exercise program can
improve cardiovascular endurance.
Flexibility

The Wilcoxon signed rank test showed no significant improvements in flexibility as
measured by the sit and reach. However, the visual interpretation of the graphs suggests that all
participants improved flexibility throughout the duration of the program. Burnham and Wilcox
(2002) have noted similar increases in lower body flexibility following a 10-week protocol with
breast cancer survivors. Cheema and Gaul (2006) further supported this finding with
improvements in lower body flexibility found in breast cancer survivors following an eight-week
study. The results from this study help to strengthen previous research highlighting the efficacy
of a supervised exercise program carried out three times a week for 15 weeks at increasing
flexibility in breast cancer survivors. An increase in flexibility may aid in restoring “normal”
function, range of motion and improve physical functioning needed for activities of daily living
(Stathokostas, Little, Vandervoory & Paterson, 2012). Thus, the inclusion of flexibility training
as a component in a training program is warranted.
Balance and Mobility

No statistically significant improvements in the Get Up and Go (GUG) test were found in
the present study. Visual interpretation suggested that 3 of the 5 participants showed a slight
improvement in the GUG test. Further improvement in balance and mobility may have been
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shown with the selection of a different test. All participants had strong baseline measurements
(compared to norms of similar age, (Bohannon, 2006; Isles, Low Choy & Steer, 2004)) on the
GUG, leaving the room for improvement marginal. Use of a different testing protocol may have
yielded more improvement among the participants. Twiss et al (2009) utilized a timed backward
tandem walk test in a study of 223 postmenopausal breast cancer survivors. The researchers
found that survivors in an exercise intervention group had statistically (p=0.010) significant
improvements in balance and mobility. It is apparent that the efficacy of an exercise program at
improving balance and mobility is unclear; although we can suggest that with the contribution of
muscle strength to balance control (Winters-stone et al, 2012), an exercise program utilizing
resistance training in breast cancer survivors can at least maintain, and in some cases improve
measures of balance and mobility.
Weight

The Wilcoxon signed rank test yielded no significant changes in weight. However, visual
inspection of the graphs showed that all participants at least maintained if not experienced a
favorable weight change. Participant one for example, lost 2.7kg throughout the program, which
a reduction from 120 to 117 can yield important health improvements, such as a reduced risk of
recurrence, increase in longevity and quality of life as a result. Cachexia is prevalent condition
following treatment, and patients often have trouble maintaining weight as a result. Participant
four was able to gain 1.5kg throughout the program, which again can have important health
implications including prevention of weight loss, particularly in a population at risk of mortality
(Morley, Thomas & Wilson, 2006). However, further research is needed to investigate the effects
of an exercise intervention on weight and body composition with survivors diagnosed with
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cachexia. The results of this study are consistent with previous literature noting improvements in
body fat percentage and lean body mass (Irwin et al, 2009, Battaligni et al, 2007) following
training interventions.
Waist-to-hip ratio

Waist to hip ratio (W/H) yielded no significant improvements through the Wilcoxon
signed rank test. Visual interpretation of the graphs showed a slight improvement in some cases.
For instances Participant one experienced a decrease of almost a decimal point throughout the
program. Several other researchers have noted significant improvements in waist and hip
measurements (Cheema & Gaul, 2006; Nuri et al, 2012). There are important clinical
implications of lowering W/H in breast cancer survivors as evidenced by Borugian et al (2003).
These authors noted each decimal increase in W/H represented a 50% increase in
postmenopausal breast cancer mortality. Thus, a lower W/H may be associated with increased
longevity in survivors and could be a practical tool of assessment in field settings where
laboratory measurements are not available. Participants in the present study experienced modest
improvements in W/H; further research is needed to determine if a longer protocol might illicit
favorable body composition changes.
Resting heart rate (RHR) and Blood Pressure (BP)

The Wilcoxon signed rank test yielded no significant differences for either RHR or BP
for the intervention. Visual inspection also yielded little variance or improvement in RHR or BP
among the participants. It is possible that the intervention of 20-30 minutes of cardiovascular
training three times a week may not have been sufficient to illicit changes in RHR and BP.
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However, this does partially support the ability of a physical activity intervention to at least
maintain RHR and BP in breast cancer survivors.
Quality of life

There were no statistically significant improvements found from analysis of the
Wilcoxon signed rank test. Visual interpretation of the results suggests that quality of life (QOL)
can at least be maintained, if not improved in some cases.
The effects of training interventions and levels of physical activity and QOL among
breast cancer survivors have been well researched. Mandelblatt et al (2011) assessed physical
activity levels of 2,279 breast cancer survivors between 2006 and 2009. The researchers found a
significant, positive correlation with QOL and physical activity. Chen et al (2010) found similar
results with participants achieving higher levels of activity being associated with a higher QOL.
Work by Schneider further supports this, with a 6-month exercise program demonstrating
significant improvements in QOL(p= .0012) in breast cancer survivors.
Gupta, Grutsch and Lis (2008) recently highlighted an important note about the use of
QOL surveys. The European Organisation for the Research and Treatment of Cancer Quality of
Life Questionnaire (QLQ-C30) and the Ferrans and Powers Quality of Life index (QLI) were
compared and found to have poor to modest correlations among the subscales of each survey (0.6
for QLQ-C30 physical and QLI health, 0.6 for QLQ-C30 role and QLI health, and 0.2 for QLQC30 social and QLI social). The authors concluded that the two instruments measure different
and unrelated aspects of QOL and may yield different results and conclusions. This study
utilized the QLI, which has four subscales: health and physical, social and economic,
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psychological and spiritual and family. Future studies may be strengthened by using instruments
to measure QOL that include functional aspects such as the QLQ-C30 (functional scales include
physical, role cognition, emotional and social, along with symptom scales including fatigue, pain
and insomnia). This may provide a better insight as to the mechanisms of improving QOL
through physical activity.
Adherence

Six participants started the study; however due to an extended vacation towards the end of
the study, one participant dropped out (although this participants adherence rate to the protocol
up until dropout was 100%). For the participants who completed the study, the intervention
consisted of three sessions a week for fifteen weeks, yielding a total of 45 sessions for each
participant to attend. Overall, a total of 7 sessions were missed between the participants, yielding
a 97% adherence rate for this intervention. This adherence rate is higher than seen in previous
studies; Courneya et al (2008) found an adherence rate to a supervised exercise program to be
70.2%. Interestingly, these same researchers found significant associations between exercise
adherence and the location of the center (closer), disease stage (lower disease stage), and
physical fitness (higher levels of fitness). Daley et al (2007) found similar results with a reported
77% adherence rate observed over an 8-week exercise program with breast cancer survivors. In a
more recent study, Courneya et al (2012) found an adherence rate similar to the one found in this
study with participants attending 95% of supervised exercise sessions. Courneya and colleagues
also found that the unsupervised portion of the exercise program had a lower adherence rate, a
trend that is evidenced in other literature (Halle, 2013; Lemanne, Cassileth & Gubili, 2013).
While the high adherence rate in our study is most likely due to the lower number of participants;
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all six participants had been previously inactive for at least 6 months prior to the study. This
period of inactivity suggests that they most likely would have remained sedentary or at least
refrained from performing structured physical activity prior to enrollment in this study.
Use of visual interpretation and single subject design are rare in the literature (Kinugasa,
Cerin & Hooper, 2004). However its use in the field can be supported by its ability to assess a
participant’s individual response to a stimulus. It is also important to note the difference between
statistical significance and practical significance in the field of applied research. Statistical
significance speaks to the probability that an intervention had an effect on a dependent variable
(Kinugasa, Cerin & Hooper, 2004). Conversely, practical significance refers to the practical
meaningfulness or value of the effect of an intervention in an applied setting (Kinugasa, Cerin &
Hooper, 2004).
The practical implications of this study are two-fold. Firstly, the simplicity of visual
analysis provides practitioners and health professionals a quick and straightforward method of
analyzing a participant’s response to training. Of course, error of measurement must be taken
into account with visual analysis, and the use of statistical analysis may help strengthen the
interpretation. Nevertheless, this type of design may be warranted in an applied setting where
larger participant numbers are not available or individual responses to training are of interest.
This is advantageous with a population such as breast cancer survivors where special
considerations need to be included in exercise prescription and response to an exercise program
may not represent that of an apparently healthy individual. This design allows for consistent
monitoring of response and if needed, modification to the program to enhance its effectiveness.
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Secondly, throughout the course of this study, all participants were meeting national
guidelines for physical activity (moderate-intensity activity on 5 or more days for at least 30 min
or vigorous activity on 3 or more days for at least 20 min (Harrison, Hayes, Newman, 2008)).
Despite strong evidence supporting regular physical activity in reducing breast cancer risk and
recurrence, as few as 32% of breast cancer survivors were meeting the recommended levels of
physical activity (150 min/week of moderate to vigorous-intensity sports/recreational physical
activity) Irwin et al, 2004). This study attests to the efficacy of a supervised physical activity
study at increasing physical activity levels in breast cancer survivors. This study adds strength to
the growing body of research supporting the safety and efficacy of physical activity interventions
at increasing levels of physical activity, adherence and improving physical functioning in breast
cancer survivors (Holmes, Chen, Feskanich, Kroenke, & Colditz, 2005; Sprod, 2009; Schmitz,
Kathryn H., Kerry S. Courneya, Charles Matthews, et al, 2010; Irwin, 2012; Halle, 2013;
Lemanne, Cassileth & Gubili, 2013).
Cancer survivors often experience reduced bone mineral density following treatment, and
are consequently at a greater risk for falls and injury (Chen et al, 2005). Furthermore, researchers
have utilized aqua aerobics with cancer survivors with the premise that the buoyancy of water
will reduce axial loading and allow participants to perform exercises they may not be able to on
land (Fernández-Lao, Cantarero-Villanueva, Ariza-Garcia, Courtney, Fernández-de-las-Peñas, &
Arroyo-Morales, 2013). This study adds to previous research suggesting that low-impact
exercise may reduce the load experienced on participants’ bones and joints, and can be a welltolerated and feasible alternative to regular treadmill training.
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This study is the first of its kind to examine the inclusion of an Alter-G treadmill in a
physical activity program directed at breast cancer survivors. The ability of the treadmill to
“unload” the participants and lower the pressure on their bones and joints may provide a novel
alternative to higher impact activities to improve cardiovascular functioning. This low-impact
activity may also reduce the risk of falls and fractures that may occur during traditional treadmill
training among breast cancer survivors who are at an increased risk following treatment (Chen et
al, 2005). Finally, the ability to gradually increase the percentage of bodyweight a participant can
run at, may contribute to the gradual strengthening of bones, and bone ossification.
The nature of breast cancer rehabilitation research is progressing to a more individualized
method of exercise prescription based on survivors’ treatment, level physical functioning,
limitations etc. Stout & colleagues (2012) recently presented a “Progressive Surveillance Model
(PSM)” for female breast cancer survivors. The primary goal of a PSM is to consistently monitor
and periodically assess progress of participants’ progress through an exercise program to modify
if needed, and fully optimize the exercise prescription. By monitoring levels of physical
functioning before, during, and after treatment, health professionals are able to prescribe
individualized and effective programs to optimize progress. This model allows for physical
limitations and impairments to be addressed consistently and exercises prescribed to expedite the
rehabilitation process and restore physical functioning.
Brown, Shackleford & Schneider (2013) presented a similar presence at the 2013
American College of Sports Medicine annual meeting. The researchers developed an outpatient
phase model to attempt to individualize exercise prescription for survivors based on their
progress with treatment (pre, during, post etc.) and physical functioning. Consistent with
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previous literature (Binkley et al, 2012) the researchers advocated the need for an educational
aspect about the side effects of treatment and realistic expectations for physical functioning and
Quality of Life following treatment, to be included in an intervention.
This type of AB-AB design supports the aforementioned models of individualized
prescription and adds to the recommendations for consistent and periodical surveillance and
assessment of participants’ progression through an exercise intervention and attempt to optimize
prescription. All testing used well-utilized field methods that could be easily replicated. Testing
time was minimal with the excepting for cardiovascular testing which was simultaneously used
as an exercise session. Health professional may find use from this model of consistent
assessment to provide the participant with visual encouragement, provide third party payers and
physicians with simple and easy to interpret visual analysis of progress, and finally as a means of
assessing the effectiveness of the program.
Limitations

This study had several limitations. The small sample size makes it difficult to generalize to a
larger population of survivors. However, the benefit of this type of study design allows for each
participant to be his or her own control. This gives the unique advantage of being able to analyze
individual results rather than as a group. Research of this nature highlights the individual
response to exercise and supports the idea that variability in treatment received, duration of
treatment, age, time since diagnosis, severity of disease, among others, may affect the response
of breast cancer survivors to exercise (Schmitz, Kathryn H., Kerry S. Courneya, Charles
Matthews, et al, 2010; Irwin, 2012).
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Lengths of the baseline phases were two weeks apiece. Future studies may be strengthened
by administering longer baseline phases between intervention phases to allow for a longer period
of deconditioning. This in turn may make it easier to infer that it was the intervention that caused
changes. This study took place in a small southeastern rural town and thus may not be
generalizable to other geographical areas. The lack of laboratory tests may also be a limitation,
particularly methods of assessing cardiorespiratory fitness and body composition. Future studies
may be strengthened by more robust methods of assessment such as gas exchange analysis to
determine VO2max and Dual X-ray absorptiometry to evaluate changes in fat mass and lean
body mass.
Conclusion and Implications

In conclusion, the results of this study suggest that participation in a 15-week supervised
intervention with the inclusion of an Anti-gravity treadmill may provide practical and
meaningful improvements in physiological and psychosocial variables in female breast cancer
survivors. Further research should include a larger population more representative of the general
breast cancer population. The use of longer baseline periods may give a better indication of the
effects of the intervention.
There is a growing body of literature supporting physical activity as a means to attenuate
the negative side effects of cancer treatment such as pain, fatigue, lymphedema, weakness,
restricted range of motion, neuropathy, & reduced bone density (Sprod, 2009; Irwin, 2012;
Siegal, R., DeSantis, C., Virgo, K., Stein , K. et al, 2012). Despite this, there remains to be a low
level of survivors meeting the National guidelines for minimal physical activity. The apparent
inconsistency of physician recommendations for physical activity, as well as lack of third party
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compensation for rehabilitation programs may provide a possible reason for survivors’ lack of
physical activity and participation in supervised exercise programs (Blaney, Lowe-Strong,
Campbell, Allen et al, 2010). Thus it is imperative to establish a collaborative relationship
between exercise specialists and physicians to increase awareness of current guidelines and
programs available. Furthermore, there is a need for more studies contributing to the current
body of literature supporting physical activity as a primary component of cancer care and
rehabilitation. Future research will help support the inclusion of physical activity as a primary
component of cancer treatment and recovery (Irwin, 2008) and provide policy makers and third
party payers with the sufficient evidence for reimbursing cancer survivors for treatment and
counseling (Irwin, 2008; Schmitz, 2010).
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Appendices
A. PHYSICIAN RELEASE FORM

Physician Approval Form.

Date______
Dear Doctor:
Your patient _____________________________________________ wishes to take part
in a physical activity program with concurrent assessments. The program may include
progressive resistance training, flexibility exercises, and a cardiovascular program; increasing in
duration and intensity over time depending on the participant’s ability. The fitness assessment
will include a sub-maximal cardiovascular fitness test and measurements of body composition,
flexibility, and mobility. (Details of the program are in the attached information packet.)
Please indicate if there are any special precautions or considerations for this individual to
limit his/her participation in the program. (i.e. current medical condition: risk of bone metastases
or osteoporosis, presence of lymphedema, hematological parameters etc.)
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
For physician signature only:
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I, ____________________________, have reviewed the proposed program and approve
of my patient ______________________________ participating in the above-described program
while undergoing chemotherapy, radiation therapy, or other active cancer treatments. I
recommend the aforementioned adaptations for my patient’s safety.
Print Name ___________________

Signature _____________________

Program Details:
The purpose of this study is to determine if using an anti-gravity (Alter-G) treadmill in
combination with a physical activity program will aid in improving physiological and
psychosocial measures in female breast cancer survivors.

The program will include a screening week where participants will fill out informed
consent forms and be given an overview of what the study will consist of.

Participation in this research will include completion of a training program administered
by specialized health professionals. It will consist of 16 total weeks of participation. The first 2
weeks will comprise of testing to establish an initial evaluation of baseline performance.
Following this will be a 4 week period of an exercise program compromising of cardiovascular,
resistance and flexibility training. Following this period there
will be a 2-3week return to baseline phase where the participant
will not participate in the exercise program but will be
continuously assessed throughout the period. The final 4 week
phase represents a return to exercise phase where participants
will take part in the same exercise program as before. (A
detailed outline of sessions is provided below).The intervention
will be modified to each individual based on medical history,
prior history of exercise, any physical limitations as a result of treatment along with any
physician notes about a participant.
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The Alter-G treadmill operates in a similar fashion to a regular treadmill with the
exception of a chamber surrounding the participant at waist-level. This chamber attached to
specially modified shorts worn by the participant & calibrates to match air pressure to the
patient’s body weight. After calibration, the treadmill can then increase air pressure inside the
chamber to decrease the load on the participant. Participants will be asked to walk or run at a
percentage of their body weight for a specified period of time. The treadmill will be used in each
training phase. The treadmill is FDA approved, covered by many health insurance plans along
with being used at physical therapy facilities, and collegiate & professional sports teams
nationwide.
Visit 1- Week 1
-Will consist of initial screening and testing. Participants will be given an orientation into
the study and an overview of the timeline.
Visit 2- Week 1
-Baseline testing will consist of measuring resting heart rate & blood pressure at the
beginning of the session.
Balance
-Functional balance will be measured with a timed “Get-up-and-Go” (GUG) test. The
GUG test consists of time measurements of the participants starting from a seated position,
standing without the help from their hands, walking forward three meters, turning around,
walking back to the chair, and sitting down without use of their hands. Time will be measured in
seconds.
Flexibility
-A modified sit and reach test will be used to measure flexibility. Participants sit in a
chair with one leg outstretched. They the slide their hands as far down their outstretched leg as
possible. Flexibility will be measured by the distance between the participant’s fingertips and
their toes.
Body composition (Skinfold Calipers)
-A Skinfold Caliper is a specially designed piece of equipment used for taking
measurements of subcutaneous tissue. Measurements are obtained from either a 3-fold or a 7fold site. These measurements are inputted into an equation to estimate body fat percentage.
Quality of Life
-Measured using Ferrans and Powers QUALITY OF LIFE INDEX© CANCER
VERSION – III. This is a survey used to establish a client’s satisfactions in various areas of their
life.
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Visit 3- Week 1
-This will comprise of the same testing measures as Baseline Testing (BT) with the
addition of an estimated VO2 max test designed to measure oxygen consumption and aerobic
capacity.
Visit 4-6- Week 2
-These visits will have the same procedure as baseline testing.
Visit 7-19 Weeks 3-7
-These visits will include the training sessions as interventions. BT will be performed at
the beginning of each session, followed by a combination of resistance, aerobic and flexibility
training.

Visit 20-29 Weeks 8-11
-Intervention will be removed and in a ‘return to baseline phase’ BT will be carried out
through each visit throughout this phase.
Visit 30-42 Weeks 12-16
-Return to treatment. Training protocol will be reintroduced. Procedure for this phase will
be the same as visits 7-19.

104

B. Informed Consent

COLLEGE OF (HEALTH AND HUMAN SERVICES)

DEPARTMENT OF (KINESIOLOGY & HEALTH
PROMOTION)

INFORMED CONSENT

●

The purpose of this research is to examine the effects of a physical therapy program including an
anti-gravity treadmill in improving physical functioning and Quality of Life in female breast
cancer survivors.

●

Participation in this research will include completion of a training program administered by
specialized health professionals. The training program is being provided as a substitute to the
normal physical therapy program. Participation in this research will be done as a SUBSTITUTE
to a regular physical therapy, NOT in addition to. However, this program is designed following
the latest research and guidelines on the safety and efficacy of training cancer survivors. Thus you
will expect to see improvements in physical functioning, mood, self-esteem and possibly overall
quality of life. One dissimilarity between this program and what typically may be seen in a
regular therapy program is the presence of two baseline phases (6weeks total) where the
participant will be not be given any intervention with the exception of baseline testing (detailed
below). This represents a phase of physical deconditioning not seen in typical programs. However
the initial baseline phase will allow the participant to become acclimated with the setting,
exercises and modes of testing; the return to baseline may provide a period of lower activity to
provide the participant with a “break before resuming the final replication stage.” It will consist
of 16 total weeks of participation. The first 2 weeks will comprise of testing to establish an initial
evaluation of baseline performance. Following this will be a 4 week period of an exercise
program compromising of cardiovascular, resistance and flexibility training. Following this
period there will be a 2-3week return to baseline phase where the participant will not participate
in the exercise program but will be continuously assessed throughout the period. The final 4 week
phase represents a return to exercise phase where participants will take part in the same exercise
program as before. The Alter-G treadmill operates in a similar fashion to a regular treadmill with
the exception of a chamber surrounding the participant at waist-level. This chamber attached to
specially modified shorts worn by the participant &calibrates to match air pressure to the patient’s
body weight. After calibration, the treadmill can then increase air pressure inside the chamber to
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decrease the load on the participant. You will be asked to walk or run at a percentage of your
body weight for a specified period of time. The treadmill will be used in each training phase.
●

Discomforts and Risks:
By participating in this research, there exists a remote possibility of some adverse changes during
the study. These include dizziness, abnormal blood pressure, irregular heartbeat, fainting, stroke,
or death. I understand that every effort will be made to minimize these risks by evaluating
preliminary health information prior to testing. An initial fitness assessment will allow for an
individualized training program which will be monitored closely by trained exercise specialists to
ensure risks are optimally minimized. Emergency equipment is available and personnel trained in
CPR, AED and first aid will be available to deal with any unusual situations. “I understand that
medical care is available in the event of injury resulting from research but that neither financial
compensation nor free medical treatment is provided. I also understand that I am not waiving any
rights that I may have against the University for Injury resulting from negligence of the
University or investigators.” Further information can be obtained by consulting the Principal
Investigator, Ciaran Fairman, who can refer you to the appropriate health services.

●

Benefits:
It is possible that you will receive some benefit from this study which may include: improved
physical functioning, improved outlook on life, & reduced risk of recurrence. This study may also
show results that will pave the way for future research to evaluate the efficacy and significance of
using an anti-gravity treadmill in a rehabilitation program for Breast Cancer survivors.

●

The program will consist of training & testing 3 days a week for 14 weeks.

●

Statement of Confidentiality All data and information provided will remain private and
confidential. Only the principal investigator, Ciaran Fairman, and the faculty advisor, will have
access to your information. Data will be stored in a secure location for 7 years.

●

Right to Ask Questions: Participants have the right to ask questions and have those questions
answered. If you have questions about this study, please contact the principal investigator, Ciaran
Fairman, at 912-536-2096 or the faculty advisor, Jim McMillan whose contact information is
located at the end of the informed consent. For questions concerning your rights as a research
participant, contact Georgia Southern University Office of Research Services and Sponsored
Programs at 912-478-0843.

●

You are under no obligation to participate in this research and may end your participation by
letting the person in charge of your decision.

●

There is no penalty from deciding not to participate in the study. At any point if you feel you
don’t want to participate further in the study you may withdraw without penalty or retribution.
Withdrawing from this study does not exclude you from participating in other available physical
therapy programs as recommended by your physician or physical therapist

●

You must be 18 years of age or older to consent to participate in this research study. If you
consent to participate in this research study and to the terms above, please sign your name and
indicate the date below
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You will be given a copy of this consent form to keep for your records. This project has been reviewed
and approved by the GSU Institutional Review Board under tracking number H13160
Title of Project: Effectiveness of a training program using an Alter-G treadmill to improve
physiological and psychosocial measures in female breast cancer survivors
Principal Investigator: Ciaran Fairman, 212 A Nature Way, Statesboro, GA, 30458. 912-536-2096.
cf02129@georgiasouthern.edu
Other Investigator(s): Brandonn Harris, c/o Department of Health & Kinesiology, Georgia Southern
University, 1332 Southern Drive, Statesboro, Georgia 30458, (912) 478-7900 and
bharris@georgiasouthern.edu)
Kristina Kendall, c/o Department of Health & Kinesiology, Georgia Southern University, 1332 Southern
Drive, Statesboro, Georgia 30458,
Faculty Advisor: (JimMcMillan, c/o Department of Health & Kinesiology, Georgia Southern University,
1332 Southern Drive, Statesboro, Georgia 30458, (912) 478-0200, jmcmillan@GeorgiaSouthern.edu)

______________________________________
Participant Signature

_____________________
Date

I, the undersigned, verify that the above informed consent procedure has been followed.
______________________________________
Investigator Signature

_____________________
Date
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C. RECRUITMENT FLYER
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D. QUALITY OF LIFE SCALE
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E. BALKE TREADMILL PROTOCOL
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F. Contraindications to Exercise
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